ipatasertib Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Male only (1)
Any (2)

Phase 1 (2)
Phase 2 (1)

Interventional (3)

Dana-Farber Cancer Institute (1)
Hoffmann-La Roche (1)
SOLTI Breast Cancer Research Group (1)

No (3)

No (3)

Adult (18+) (3)

I am/have/had

I am/have/hadcancer

I am/have/hadbreast irradiation

I am/have/hadbilateral breast cancer

I am/have/hadimmunohistochemistry

I am/have/hadHER2

I am/have/hadtargeted therapy

I am/have/hadgilbert's syndrome

I am/have/hadglomerular filtration rate

I am/have/hadmetastatic adenocarcinoma

I am/have/hadmastectomy

I am/have/hadbone lesions

I am/have/hadformalin-fixed paraffin-embedded

I am/have/hadbone metastases

I am/have/hadhysterectomy

I am/have/hadbreast cancer

I am/have/hadanticoagulation therapy

I am/have/hadmetastatic hormone refractory prostate cancer

I am/have/hadaxillary lymph node dissection

I am/have/hadher2-positive breast cancer

I am/have/hadffpe

added new label for I am/have/had

I am looking for

I am looking fordocetaxel

I am looking foripatasertib

I am looking forimmunological adjuvant

I am looking forimmunomodulators

I am looking foratezolizumab

I am looking forgnrh

I am looking forglycosylated hemoglobin

I am looking forimmunostimulant

I am looking forcolony stimulating factor

I am looking forg-csf

I am looking forprobe

I am looking forgranulocyte colony stimulating factor

I am looking forpertuzumab

I am looking foradjuvant

I am looking fortestosterone

I am looking forgonadotropin releasing hormone

I am looking fortaxane

I am looking foranticoagulants

I am looking forhba1c

I am looking forcfdna

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

A Study Evaluating The Safety Efficacy and Pharmacokinetics Of Ipatasertib In Combination With Atezolizumab And Docetaxel In Metastatic Castration-Resistant Prostate Cancer (mCRPC).

A study evaluating the safety, preliminary efficacy and pharmacokinetics of ipatasertib in combination with atezolizumab and docetaxel in participants with mCRPC previously treated with second-generation AR (Androgen Receptor)-targeted therapy.

docetaxel

prostate adenocarcinoma

cancer

metastatic hormone refractory prostate cancer

atezolizumab

0 views
19 Feb, 2024

Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients

This is an open label, single arm, multicenter, phase Ib study to evaluate the safety and clinical activity of the combination of ipatasertib, trastuzumab and pertuzumab in patients with unresectable locally advanced or metastatic HER2-positive breast cancer with tumors harboring PIK3CA mutations, candidates to receive maintenance HP after first line …

breast adenocarcinoma

cancer

immunological adjuvant

neutrophil count

adenocarcinoma of the breast

0 views
19 Feb, 2024

Ipatasertib + Atezolizumab to Prevent Recurrence in TNBC

This research study involves the following investigational drugs: Ipatasertib Atezolizumab

cancer

immunomodulators

breast irradiation

immunohistochemistry

platelet count

0 views
19 Feb, 2024